Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuti

Showing results (131-140 of 596) with videos related to

Pageof 60
Sort By:
IEEE Transactions on Cybernetics|July 12, 2022
Computationally Relaxed Unscented Kalman FilterJozsef Kuti, Imre J Rudas, Huijun Gao, et al.
West African Journal of Medicine|March 12, 2022
Heavy Malaria Parasitaemia in Young Nigerian Infants: Prevalence, Determinants and Implication for the Health SystemO F Folarin, B P Kuti, A O Oyelami
Connecticut Medicine|August 28, 2009
Clostridium difficile infection--not just a burden anymoreCatharine C Bulik, Joseph L Kuti, David P Nicolau
The Pan African Medical Journal|July 9, 2020
Relationship between serum insulin and point-of-admission blood glucose of ill neonates at a tertiary health facility in NigeriaEmmanuel Oluwatosin Adeniji, Bankole Peter Kuti, Jerome Boluwaji Elusiyan
Paediatric Drugs|April 13, 2006
Pharmacodynamic evaluation of meropenem and cefotaxime for pediatric meningitis: a report from the OPTAMA programJennifer M Ellis, Joseph L Kuti, David P Nicolau
Connecticut Medicine|August 24, 2005
Questioning the paradigm: monotherapy vs combination antimicrobial therapy for treatment of Pseudomonas aeruginosaC Andrew DeRyke, Joseph L Kuti, David P Nicolau
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Pharmacodynamics of antimicrobials: treatment optimisationEffie L Gillespie, Joseph L Kuti, David P Nicolau
Clinical Therapeutics|December 22, 2005
Use of Monte Carlo simulation to assess the pharmacodynamics of beta-lactams against Pseudomonas aeruginosa infections in children: a report from the OPTAMA programJennifer M Ellis, Joseph L Kuti, David P Nicolau
Antimicrobial Agents and Chemotherapy|May 5, 2025
<i>Ex vivo</i> assessment and simulation to guide cefepime-taniborbactam dosing recommendations for patients receiving continuous renal replacement therapyAliaa Fouad, Cole McGrath, Ecem Buyukyanbolu, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2013
Clinical pharmacodynamics of antipseudomonal cephalosporins in patients with ventilator-associated pneumoniaShawn H MacVane, Joseph L Kuti, David P Nicolau
Pageof 60

Showing results (131-140 of 596) with videos related to

Sort By:
Pageof 60
IEEE Transactions on Cybernetics|July 12, 2022
Computationally Relaxed Unscented Kalman FilterJozsef Kuti, Imre J Rudas, Huijun Gao, et al.
West African Journal of Medicine|March 12, 2022
Heavy Malaria Parasitaemia in Young Nigerian Infants: Prevalence, Determinants and Implication for the Health SystemO F Folarin, B P Kuti, A O Oyelami
Connecticut Medicine|August 28, 2009
Clostridium difficile infection--not just a burden anymoreCatharine C Bulik, Joseph L Kuti, David P Nicolau
The Pan African Medical Journal|July 9, 2020
Relationship between serum insulin and point-of-admission blood glucose of ill neonates at a tertiary health facility in NigeriaEmmanuel Oluwatosin Adeniji, Bankole Peter Kuti, Jerome Boluwaji Elusiyan
Paediatric Drugs|April 13, 2006
Pharmacodynamic evaluation of meropenem and cefotaxime for pediatric meningitis: a report from the OPTAMA programJennifer M Ellis, Joseph L Kuti, David P Nicolau
Connecticut Medicine|August 24, 2005
Questioning the paradigm: monotherapy vs combination antimicrobial therapy for treatment of Pseudomonas aeruginosaC Andrew DeRyke, Joseph L Kuti, David P Nicolau
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Pharmacodynamics of antimicrobials: treatment optimisationEffie L Gillespie, Joseph L Kuti, David P Nicolau
Clinical Therapeutics|December 22, 2005
Use of Monte Carlo simulation to assess the pharmacodynamics of beta-lactams against Pseudomonas aeruginosa infections in children: a report from the OPTAMA programJennifer M Ellis, Joseph L Kuti, David P Nicolau
Antimicrobial Agents and Chemotherapy|May 5, 2025
<i>Ex vivo</i> assessment and simulation to guide cefepime-taniborbactam dosing recommendations for patients receiving continuous renal replacement therapyAliaa Fouad, Cole McGrath, Ecem Buyukyanbolu, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2013
Clinical pharmacodynamics of antipseudomonal cephalosporins in patients with ventilator-associated pneumoniaShawn H MacVane, Joseph L Kuti, David P Nicolau
Pageof 60